References
- 1. Z. Yang, C. Weian, H. Susu and W. Hanmin, Protective effects of mangiferin on cerebral ischemiareperfusion injury and its mechanisms, Eur. J. Pharmacol. 771 (2015) 145–151; https://doi.org/10.1016/j.ejphar.2015.12.00310.1016/j.ejphar.2015.12.00326656757
- 2. R. H. Lee, M. H. Lee, C. Y. Wu, A. Couto e Silva, H. E. Possoit, T. H. Hsieh, A. Minagar and H. W. Lin, Cerebral ischemia and neuroregeneration, Neural Regen. Res. 13 (2018) 373–385; https://doi.org/10.4103/1673-5374.22871110.4103/1673-5374.228711590049029623912
- 3. W. Li and S. Yang, Targeting oxidative stress for the treatment of ischemic stroke: Upstream and downstream therapeutic strategies, Brain Circ. 2 (2016) 153–163; https://doi.org/10.4103/2394-8108.19527910.4103/2394-8108.195279612622430276293
- 4. R. L. Jayaraj, S. Azimullah, R. Beiram, F. Y. Jalal and G. A. Rosenberg, Neuroinflammation: friend and foe for ischemic stroke, J. Neuroinflammation 16 (2019) Article ID 142 (24 pages); https://doi.org/10.1186/s12974-019-1516-210.1186/s12974-019-1516-2661768431291966
- 5. D. Lin, L. Wang, S. Yan, Q. Zhang, J. H. Zhang and A. Shao, The role of oxidative stress in common risk factors and mechanisms of cardio-cerebrovascular ischemia and depression, Oxid. Med. Cell. Longev. 2019 (2019) Article ID 2491927 (13 pages); https://doi.org/10.1155/2019/249192710.1155/2019/2491927704448032148646
- 6. O. A. Harari and J. K. Liao, NF-κB and innate immunity in ischemic stroke, Ann. N. Y. Acad. Sci. 1207 (2010) 32–40; https://doi.org/10.1111/j.1749-6632.2010.05735.x10.1111/j.1749-6632.2010.05735.x380709720955423
- 7. M. Kawabori and M. A. Yenari, Inflammatory responses in brain ischemia, Curr. Med. Chem. 22 (2015) 1258–1277; https://doi.org/10.2174/092986732266615020915403610.2174/0929867322666150209154036556803925666795
- 8. T. Shichita, M. Ito and A. Yoshimura, Post-ischemic inflammation regulates neural damage and protection, Front. Cell. Neurosci. 8 (2014) Article ID 319 (8 pages); https://doi.org/10.3389/fncel.2014.0031910.3389/fncel.2014.00319419654725352781
- 9. C. Pop, L. Vlase and M. Tamas, Natural resources containing arbutin. Determination of arbutin in the leaves of Bergenia crassifolia (L.) Fritsch. acclimated in Romania, Not. Bot. Hortic. Agrobot. Cluj-Napoca 37 (2009) 129–132; https://doi.org/10.15835/nbha3713108
- 10. F. Yousefi, S. Mahjoub, M. Pouramir and F. Khadir, Hypoglycemic activity of Pyrus biossieriana Buhse leaf extract and arbutin: Inhibitory effects on alpha amylase and alpha glucosidase, Casp. J. Int. Med. 4 (2013) 763–767.
- 11. F. Khadir, M. Pouramir, S. G. Joorsaraee, F. Feizi, H. Sorkhi and F. Yousefi, The effect of arbutin on lipid peroxidation and antioxidant capacity in the serum of cyclosporine-treated rats, Casp. J. Int. Med. 6 (2015) 196–200.
- 12. M. E. Shahaboddin, M. Pouramir, A. A. Moghadamnia, H. Parsian, M. Lakzaei and H.Mir, Pyrus biossieriana Buhse leaf extract: An antioxidant, antihyperglycaemic and antihyperlipidemic agent, Food Chem. 126 (2011) 1730–1733; https://doi.org/10.1016/j.foodchem.2010.12.06910.1016/j.foodchem.2010.12.06925213951
- 13. B. E. Myagmar, E. Shinno, T. Ichiba and Y. Aniya, Antioxidant activity of medicinal herb Rhodococcum vitis-idaea on galactosamine-induced liver injury in rats, Phytomedicine 11 (2004) 416–423; https://doi.org/10.1016/j.phymed.2003.04.00310.1016/j.phymed.2003.04.00315330497
- 14. S. R. Ahmadian, M. Ghasemi-Kasman, M. Pouramir and F. Sadeghi, Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy, Neuropharmacology 146 (2019) 117–127; https://doi.org/10.1016/j.neuropharm.2018.11.03810.1016/j.neuropharm.2018.11.03830503994
- 15. H. J. Lee and K. W. Kim, Anti–inflammatory effects of arbutin in lipopolysaccharide-stimulated BV2 microglial cells, Inflamm. Res. 61 (2012) 817–825; https://doi.org/10.1007/s00011-012-0474-210.1007/s00011-012-0474-222487852
- 16. M. Dadgar, M. Pouramir, Z. Dastan, M. Ghasemi-Kasman, M. Ashrafpour, A. A. Moghadamnia, S. Khafri and M. Pourghasem, Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson’s disease, Avicenna J. Phytomed. 8 (2018) 533–542.
- 17. Y. Ding, D. Kong, T. Zhou, N.-D. Yang, C. Xin, J. Xu, Q. Wang, H. Zhang, Q. Wu, X. Lu, K. Lim, B. Ma, C. Zhang, L. Li and W. Huang, α-Arbutin protects against Parkinson’s disease-associated mitochondrial dysfunction in vitro and in vivo, Neuromol. Med. 22 (2019) 56–67; https://doi.org/10.1007/s12017-019-08562-610.1007/s12017-019-08562-631401719
- 18. Z. Dastan, M. Pouramir, M. Ghasemi-Kasman, Z. Ghasemzadeh, M. Dadgar, M. Gol, M. Ashraf-pour, M. Pourghasem, A. A. Moghadamnia and S. Khafri, Arbutin reduces cognitive deficit and oxidative stress in animal model of Alzheimer’s disease, Int. J. Neurosci. 129 (2019) 1145–1153; https://doi.org/10.1080/00207454.2019.163837610.1080/00207454.2019.163837631251091
- 19. J. X. Wu, L. Y. Zhang, Y. L. Chen, S. S. Yu, Y. Zhao and J. Zhao, Curcumin pretreatment and post-treatment both improve the antioxidative ability of neurons with oxygen-glucose deprivation, Neural. Regen. Res. 10 (2015) 481–489; https://doi.org/10.4103/1673-5374.15370010.4103/1673-5374.153700439611425878600
- 20. J. Ye and Y. Zhang, Curcumin protects against intracellular amyloid toxicity in rat primary neurons, Int. J. Clin. Exp. Med. 5 (2012) 44–49.
- 21. L. Wang, L. Zhang, Z. B. Chen, J. Y. Wu, X. Zhang and Y. Xu, Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1, Eur. J. Pharmacol. 609 (2009) 40–44; https://doi.org/10.1016/j.ejphar.2009.03.03310.1016/j.ejphar.2009.03.03319303870
- 22. J. Xiang, Y. P. Tang, Z. Y. Zhou, P. Wu, Z. Wang, M. Mori and D. F. Cai, Apocynum venetum leaf extract protects rat cortical neurons from injury induced by oxygen and glucose deprivation in vitro, Can. J. Physiol. Pharmacol. 88 (2010) 907–917; https://doi.org/10.1139/y10-06910.1139/Y10-069
- 23. W. Zhao, S. Wang, T. Qin and W. Wang, Arbutin attenuates hydrogen peroxide-induced oxidative injury through regulation of microRNA-29a in retinal ganglion cells, Biomed. Pharmacother. 112 (2019) Article ID 108729; https://doi.org/10.1016/j.biopha.2019.10872910.1016/j.biopha.2019.10872930970524
- 24. D. Gao, T. Huang, X. Jiang, S. Hu, L. Zhang and Z. Fei, Resveratrol protects primary cortical neuron cultures from transient oxygen-glucose deprivation by inhibiting MMP-9, Mol. Med. Rep. 9 (2014) 2197–2204; https://doi.org/10.3892/mmr.2014.208610.3892/mmr.2014.208624682241
- 25. J. Wu, Q. Li, X. Wang, S. Yu, L. Li, X. Wu, Y. Chen, J. Zhao and Y. Zhao, Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway, PLoS ONE 8 (2013) e59843 (9 pages); https://doi.org/10.1371/journal.pone.005984310.1371/journal.pone.0059843361087923555802
- 26. R. AlJohri, M. AlOkail and S. H. Haq, Neuroprotective role of vitamin D in primary neuronal cortical culture, eNeurologicalSci 14 (2018) 43–48; https://doi.org/10.1016/j.ensci.2018.12.00410.1016/j.ensci.2018.12.004631286030619951
- 27. J. Chen-Roetling, L. Chen and R. F. Regan, Minocycline attenuates iron neurotoxicity in cortical cell cultures, Biochem. Biophys. Res. Commun. 386 (2009) 322–326; https://doi.org/10.1016/j.bbrc.2009.06.02610.1016/j.bbrc.2009.06.026278294419523448
- 28. P. B. Godkar, R. K. Gordon, A. Ravindran and B. P. Doctor, Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat fore-brain neuronal cells, Phytomedicine 13 (2006) 29–36; https://doi.org/10.1016/j.phymed.2003.11.01110.1016/j.phymed.2003.11.01116360930
- 29. M. G. Ryou and R. T. Mallet, An in vitro oxygen-glucose deprivation model for studying ischemiareperfusion injury of neuronal cells, Methods Mol. Biol. 1717 (2018) 229–235; https://doi.org/10.1007/978-1-4939-7526-6_1810.1007/978-1-4939-7526-6_1829468596
- 30. T. S. Anthonymuthu, E. M. Kenny and H. Bayır, Therapies targeting lipid peroxidation in traumatic brain injury, Brain Res. 1640 (2016) 57–76; https://doi.org/10.1016/j.brainres.2016.02.00610.1016/j.brainres.2016.02.006487011926872597
- 31. A. Nurmi, P. J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M. L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger and J. Koistinaho, Nuclear factor-kappaB contributes to infarction after permanent focal ischemia, Stroke 35 (2004) 987–991; https://doi.org/10.1161/01.STR.0000120732.45951.2610.1161/01.STR.0000120732.45951.2614988572